APPB (Applied Biosciences) Operating Income: $-2.68 Mil (TTM As of Dec. 2019)


APPB Applied Biosciences Corp APPB
12 GF Score
Price $0.00
View Full Analysis

What is Applied Biosciences Operating Income?

Applied Biosciences APPB 12 Operating Income is $-2.68 Mil as of Dec. 2019. GuruFocus rates APPB with a GF Score™ of 12/100.

Applied Biosciences's Operating Income for the three months ended in Dec. 2019 was $-0.97 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2019 was $-2.68 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Applied Biosciences's Operating Income for the three months ended in Dec. 2019 was $-0.97 Mil. Applied Biosciences's Revenue for the three months ended in Dec. 2019 was $0.17 Mil. Therefore, Applied Biosciences's Operating Margin % for the quarter that ended in Dec. 2019 was -570.59%.

Applied Biosciences's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Applied Biosciences's annualized ROC % for the quarter that ended in Dec. 2019 was -97.00%. Applied Biosciences's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2019 was -1,013.84%.

Applied Biosciences  (OTCPK:APPB) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Applied Biosciences's annualized ROC % for the quarter that ended in Dec. 2019 is calculated as:

ROC % (Q: Dec. 2019 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2019 ) + Invested Capital (Q: Dec. 2019 ))/ count )
=-3.88 * ( 1 - 0% )/( (3.909 + 4.091)/ 2 )
=-3.88/4
=-97.00 %

where

Invested Capital(Q: Sep. 2019 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.484 - 0.636 - ( 0.073 - max(0, 1.323 - 0.262+0.073))
=3.909

Invested Capital(Q: Dec. 2019 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.418 - 1.132 - ( 0.021 - max(0, 2.019 - 0.214+0.021))
=4.091

Note: The Operating Income data used here is four times the quarterly (Dec. 2019) data.

2. Joel Greenblatt's definition of Return on Capital:

Applied Biosciences's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2019 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2019 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2019  Q: Dec. 2019
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-5.348/( ( (0.373 + max(-0.643, 0)) + (0.682 + max(-1.173, 0)) )/ 2 )
=-5.348/( ( 0.373 + 0.682 )/ 2 )
=-5.348/0.5275
=-1,013.84 %

where Working Capital is:

Working Capital(Q: Sep. 2019 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.066 + 0.106 + 0.017) - (0.636 + 0 + 0.196)
=-0.643

Working Capital(Q: Dec. 2019 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.076 + 0.102 + 0.015) - (1.132 + 0 + 0.234)
=-1.173

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2019) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Applied Biosciences's Operating Margin % for the quarter that ended in Dec. 2019 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2019 )/Revenue (Q: Dec. 2019 )
=-0.97/0.17
=-570.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Applied Biosciences Operating Income Related Terms

Applied Biosciences Operating Income Historical Data

* Premium members only.

The historical data trend for Applied Biosciences's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Biosciences Operating Income Chart

Applied Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18
Operating Income
-0.00 -0.02 -0.03 -0.14 -1.49

Applied Biosciences Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.39 -0.41 -0.48 -0.82 -0.97
APPB
12GF Score
Applied Biosciences Corp APPB
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied Biosciences Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of $-2.68 Mil mean?
Applied Biosciences (APPB) has a Operating Income of $-2.68 Mil as of Dec. 2019. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Applied Biosciences and its competitors.
Is Applied Biosciences' Operating Income too high?
Applied Biosciences' current Operating Income is $-2.68 Mil. Overall, Applied Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Applied Biosciences' Operating Income compare to CNABQ and OWCP?
Applied Biosciences' Operating Income of $-2.68 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Drug Manufacturers company?
A good Operating Income depends on the Drug Manufacturers industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Applied Biosciences and its competitors. Applied Biosciences's current Operating Income is $-2.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied Biosciences stock overvalued right now?
Applied Biosciences (APPB) has a current Operating Income of $-2.68 Mil. The current Operating Income is $-2.68 Mil. Applied Biosciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Applied Biosciences (APPB), the current Operating Income is $-2.68 Mil as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Applied Biosciences Business Description

Address 112 North Curry Street, 18th Floor, Carson, NY, USA, 89703
Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.
12GF Score

Get the complete analysis for APPB

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price